18Suppliers
22Customers
1Debt Items
20Related Chains

Fulgent Genetics, Inc. Suppliers

TickerNameConfidenceEvidence
ABT Abbott Laboratories 92% supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sole provider of maintenance and repair services for these sequencers; on Roche Holdi…
ABT Abbott Laboratories 92% Reciprocal relationship from ABT graph: Reciprocal relationship from FLGT graph: supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sole…
BECKMAN-COULTER-DIAGNOSTICS BECKMAN-COULTER-DIAGNOSTICS 92% we rely on Beckman Coulter Diagnostics for certain laboratory equipment, supplies, and services for our flow cytometry tests and testing services
LEICA-BIOSYSTEMS LEICA-BIOSYSTEMS 92% we rely on Leica Biosystems for an automated digital scanning solution to scale up digital pathology operations
ROCHE-HOLDINGS-AG ROCHE-HOLDINGS-AG 92% we rely on Roche Holdings AG for certain laboratory equipment, supplies, and services for our immunohistochemistry services
ANP-TECHNOLOGIES-INC ANP-TECHNOLOGIES-INC 90% our therapeutic development business relies on ANP Technologies, Inc. for certain laboratory services, equipment, tools, and drug intermediates in connection with our research
BNBX BNB Plus Corp. 72% Reciprocal relationship from BNBX graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from BNBX graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from BNBX g…
DGX Quest Diagnostics Incorporated 72% Reciprocal relationship from DGX graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from DGX graph: Reciprocal relationship from FLGT graph: , information technology, and service…
DGX Quest Diagnostics Incorporated 72% , information technology, and service companies may develop and sell competitive tests, which may include informatics analysis, integrated genetic tools, and services for health and wellness. We also…
EXAS Exact Sciences Corp 72% supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sole provider of maintenance and repair services for these sequencers; on Roche Holdi…
EXAS Exact Sciences Corp 72% Reciprocal relationship from EXAS graph: Reciprocal relationship from FLGT graph: supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sol…
MYGN Myriad Genetics, Inc. 72% , information technology, and service companies may develop and sell competitive tests, which may include informatics analysis, integrated genetic tools, and services for health and wellness. We also…
MYGN Myriad Genetics, Inc. 72% Reciprocal relationship from MYGN graph: Reciprocal relationship from FLGT graph: , information technology, and service companies may develop and sell competitive tests, which may include informatics…
PSNL Personalis, Inc. 72% Reciprocal relationship from PSNL graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from PSNL graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from PSNL g…
TEM Tempus AI, Inc. 72% supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sole provider of maintenance and repair services for these sequencers; on Roche Holdi…
TEM Tempus AI, Inc. 72% Reciprocal relationship from TEM graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from TEM graph: Reciprocal relationship from FLGT graph: supplier of the next generation seque…
WGS GeneDx Holdings Corp. 72% Reciprocal relationship from WGS graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from WGS graph: Reciprocal relationship from FLGT graph: supplier of the next generation seque…
WGS GeneDx Holdings Corp. 72% supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sole provider of maintenance and repair services for these sequencers; on Roche Holdi…

Fulgent Genetics, Inc. Customers

TickerNameConfidenceEvidence
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS 95% USAspending awards from Department of Veterans Affairs: $84,400 across 1 awards. 36C26024P0864 GENETIC TESTING FOR VA PORTLAND HEALTH CARE SYSTEM | Qwen corrected direction: Explicit government contr…
LABORATORY-CUSTOMER LABORATORY-CUSTOMER 92% For the laboratory services segment, when customers who, to our knowledge, are under common control or otherwise affiliated with each other are aggregated, one of our laboratory customers contributed…
ABT Abbott Laboratories 72% Reciprocal relationship from ABT graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from ABT graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from ABT grap…
ABT Abbott Laboratories 72% supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sole provider of maintenance and repair services for these sequencers; on Roche Holdi…
DGX Quest Diagnostics Incorporated 72% , information technology, and service companies may develop and sell competitive tests, which may include informatics analysis, integrated genetic tools, and services for health and wellness. We also…
DGX Quest Diagnostics Incorporated 72% Reciprocal relationship from DGX graph: Reciprocal relationship from FLGT graph: , information technology, and service companies may develop and sell competitive tests, which may include informatics …
EXAS Exact Sciences Corp 72% supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sole provider of maintenance and repair services for these sequencers; on Roche Holdi…
EXAS Exact Sciences Corp 72% Reciprocal relationship from EXAS graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from EXAS graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from EXAS g…
FISI Financial Institutions, Inc. 72% Reciprocal relationship from FISI graph: Reciprocal relationship from FLGT graph: ly those with life-threatening illnesses, resulting from adverse reactions to the drugs administered during testing o…
FISI Financial Institutions, Inc. 72% ly those with life-threatening illnesses, resulting from adverse reactions to the drugs administered during testing or after product launch, respectively. Although we maintain the types and amounts o…
GH Guardant Health, Inc. 72% Reciprocal relationship from GH graph: Reciprocal relationship from FLGT graph: ry equipment, supplies, and services for our flow cytometry tests and testing services; on Leica Biosystems for an auto…
GH Guardant Health, Inc. 72% ry equipment, supplies, and services for our flow cytometry tests and testing services; on Leica Biosystems for an automated digital scanning solution to scale up digital pathology operations; and on…
MYGN Myriad Genetics, Inc. 72% Reciprocal relationship from MYGN graph: Reciprocal relationship from FLGT graph: , information technology, and service companies may develop and sell competitive tests, which may include informatics…
MYGN Myriad Genetics, Inc. 72% , information technology, and service companies may develop and sell competitive tests, which may include informatics analysis, integrated genetic tools, and services for health and wellness. We also…
TEM Tempus AI, Inc. 72% supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sole provider of maintenance and repair services for these sequencers; on Roche Holdi…
TEM Tempus AI, Inc. 72% Reciprocal relationship from TEM graph: Reciprocal relationship from FLGT graph: supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sole…
WGS GeneDx Holdings Corp. 72% Reciprocal relationship from WGS graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from WGS graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from WGS grap…
WGS GeneDx Holdings Corp. 72% supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sole provider of maintenance and repair services for these sequencers; on Roche Holdi…
AMERICA-HOLDINGS AMERICA-HOLDINGS 62% re, information technology, and service companies may develop and sell competitive tests, which may include informatics analysis, integrated genetic tools, and services for health and wellness. We al…
HEALTH-RESOURCES HEALTH-RESOURCES 62% ain the low internal costs of our business model, and to record acceptable margins on our sales; • the timing and our ability to develop our drug candidates, to satisfy the U.S. Food and Drug Adminis…
SYMPHONY-BUYER-INC SYMPHONY-BUYER-INC 62% itments with its vendors, which primarily consist of services, reagent and supplies, computer software, and medical lab equipment. As of December 31, 2024, the Company had purchase obligations of $ 4…
XILONG-SCIENTIFIC-CO XILONG-SCIENTIFIC-CO 62% xed assets United States $ 98,992 $ 77,938 $ 72,617 Foreign China 4,616 5,526 8,736 Other countries 1,941 — — Total foreign 6,557 5,526 8,736 Total $ 105,549 $ 83,464 $ 81,353 Note 8. Debt, Commitmen…

Fulgent Genetics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
FLGT-DEBT Debt stack $10.2M 90% Market cache reports total debt of $10.2M.

Fulgent Genetics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Fulgent Genetics, Inc..

Fulgent Genetics, Inc. Ownership

HolderNameConfidenceEvidence
FLGT-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 159 tracked holders.

Fulgent Genetics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
FNWB First Northwest Bancorp 100.00 2
ARMK Aramark 100.00 2
BBAR Banco BBVA Argentina S.A. 100.00 2
ENLT Enlight Renewable Energy Ltd 100.00 2
BLX Banco Latinoamericano de Comercio Exterior, S. A. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CNF CNFinance Holdings Limited 100.00 2
BMA Banco Macro S.A. 100.00 2
BSBR Banco Santander (Brasil) S.A. 100.00 2
BTTC Black Titan Corporation 100.00 2
VRNO Verano Holdings Corp. 100.00 2
AORT Artivion, Inc. 100.00 2
ARM Arm Holdings plc 100.00 2
GEMI Gemini Space Station, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 1 ['supplier']
BRBI BRBI BR Partners S.A. 100.00 2
GRAL GRAIL, Inc. 100.00 2
BRBS Blue Ridge Bankshares, Inc. 100.00 2
AVAL Grupo Aval Acciones y Valores S.A. 100.00 2
CHYM Chime Financial, Inc. 100.00 2